Carcinoid syndrome.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001063:Appendiceal Neoplasms / Q000473:pathology; D001920:Bradykinin / Q000378:metabolism; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology / Q000601:surgery; D003110:Colonic Neoplasms / Q000473:pathology; D004379:Duodenal Neoplasms / Q000473:pathology; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D007610:Kallikreins / Q000378:metabolism; D008303:Malignant Carcinoid Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology / Q000601:surgery; D008467:Meckel Diverticulum / Q000473:pathology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000473:pathology; D011379:Prognosis; D012004:Rectal Neoplasms / Q000473:pathology; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism; D013274:Stomach Neoplasms / Q000473:pathology
D000970:Antineoplastic Agents; D012701:Serotonin; D007610:Kallikreins; D001920:Bradykinin